INHIBITORS OF RETROVIRAL PROTEASE AS INDUCERS OF REVERSIBLE INSULIN RESISTANCE IN VITRO AND IN VIVO

摘要

This invention provides novel assays for measuring the metabolic side-effects of antiretroviral protease inhibitors on the Glut4 glucose transporter. The invention also provides improved methods for developing antiretroviral protease drugs, particularly those used to fight HIV infection. The invention further provides novel models of insulin-resistant glucose transport disease states.